Tobira Therapeutics, Inc. Share-based Payment Arrangement, Expense
Tobira Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $1.36 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-08-09
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2016-06-30 was $1.36M, a 254.95% increase year-over-year.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2016-03-31 was $1.19M, a 416.52% increase year-over-year.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2015-12-31 was $779.00K, a 321.08% increase year-over-year.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2015-09-30 was $860.00K.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2015 was $2.25M, a 215.99% increase from fiscal 2014.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2014 was $713.00K, a 68.56% increase from fiscal 2013.
- Tobira Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2013 was $423.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2016-06-30 | $1.36M 10-Q · filed 2016-08-09 | $2.55M 10-Q · filed 2016-08-09 | $3.33M derived: sum of 3 quarters · filed 2016-08-09 | $4.19M derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | $1.19M 10-Q · filed 2016-05-09 | $1.97M derived: sum of 2 quarters · filed 2016-05-09 | $2.83M derived: sum of 3 quarters · filed 2016-05-09 | $3.21M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-12-31 | $779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.64M derived: sum of 2 quarters · filed 2016-03-03 | $2.02M derived: sum of 3 quarters · filed 2016-08-09 | $2.25M 10-K · filed 2016-03-03 |
| 2015-09-30 | $860.00K 10-Q · filed 2015-11-10 | $1.24M derived: sum of 2 quarters · filed 2016-08-09 | $1.47M 10-Q · filed 2015-11-10 | $1.66M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-06-30 | $384.00K 10-Q · filed 2016-08-09 | $614.00K 10-Q · filed 2016-08-09 | $799.00K derived: sum of 3 quarters · filed 2016-08-09 | $118.00K derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $230.00K 10-Q · filed 2016-05-09 | $415.00K derived: sum of 2 quarters · filed 2016-05-09 | -$266.00K derived: sum of 3 quarters · filed 2016-05-09 | $799.00K derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$496.00K derived: sum of 2 quarters · filed 2016-03-03 | $569.00K derived: sum of 3 quarters · filed 2016-03-03 | $713.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | -$681.00K 10-Q · filed 2015-11-10 | $384.00K derived: sum of 2 quarters · filed 2015-11-10 | $528.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $1.06M 10-Q · filed 2015-08-11 | $1.21M 10-Q · filed 2015-08-11 | ||
| 2013-12-31 | $423.00K 10-K · filed 2016-03-03 |